பதாகை சூரியன் ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AILSA CHANG, HOST: Doctors can now prescribe a controversial new drug to their patients with Alzheimer s disease. But even medical experts are still trying to figure out which patients should get the drug and how to use it safely. NPR s Jon Hamilton reports from the Alzheimer s Association International Conference in Denver. JON HAMILTON, BYLINE: The drug, called Aduhelm, received a conditional approval from the Food and Drug Administration in June. The approval came despite conflicting evidence on whether the drug actually slows the progression of Alzheimer s. Since then, some experts have said they won t prescribe Aduhelm at all. But Dr. Alireza Atri of the Banner Sun Health Research Institute in Arizona says that would be unfair to patients and their families.

United statesMaria carrilloJon hamiltonAlireza atriEric mcdadeAlzheimer association international conference in denverBanner sun health research instituteAlzheimer associationWashington university in stAssociation international conferenceDrug administrationWashington universityAfrican americanஒன்றுபட்டது மாநிலங்களில்மரியா கரில்லோஜான் ஹாமில்டன்